{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:08:24Z","timestamp":1791842904776,"version":"4.3.4"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ThinkIn"},{"name":"Unrestricted Educational Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u00a0<\/jats:title>\n                  <jats:p>Alluzience (abobotulinumtoxinA RTU; Ipsen, Paris, France and Galderma SA, Lausanne, Switzerland) is the first ready-to-use (RTU) botulinum toxin type A liquid solution approved for the treatment of glabellar lines in Europe. In this article, the authors provide consensus recommendations on the aesthetic usage of abobotulinumtoxinA RTU. Members of the International Board on Alluzience convened to develop consensus on the treatment of glabellar lines as well as other facial wrinkles based on their own extensive experience. Consensus recommendations were developed to provide practical guidelines for injection of abobotulinumtoxinA RTU. General guidance on proper assessment, treatment planning, and patient education is provided, as well as specific injection guidelines per indication. Indications covered include glabellar lines, crow's feet, horizontal forehead lines, lateral eyebrow lift, lower eyelid wrinkles, bunny lines, drooping nasal tip, perioral wrinkles, drooping mouth corners, masseter hypertrophy, hollow cheek lines, dimpled chin, and platysmal bands. These guidelines provide a practical framework to support routine injection of facial muscles with Alluzience.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Level of Evidence: 5<\/jats:title>\n                  <jats:p\/>\n               <\/jats:sec>","DOI":"10.1093\/asj\/sjad222","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T21:57:34Z","timestamp":1690322254000},"page":"192-202","source":"Crossref","is-referenced-by-count":17,"title":["International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience)"],"prefix":"10.1093","volume":"44","author":[{"given":"Benjamin","family":"Ascher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold-Josef","family":"Rzany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kestemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Redaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Hendrickx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Iozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Martschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Milotich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Cartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Picaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna","family":"Prygova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"issue":"2","key":"2024011618052792900_sjad222-B1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1064-7406(23)00393-0","article-title":"Anatomy and pathophysiology of facial aging","volume":"9","author":"Zimbler","year":"2001","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"11","key":"2024011618052792900_sjad222-B2","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1524-4725.1998.tb04092.x","article-title":"History of the cosmetic use of botulinum A exotoxin","volume":"24","author":"Carruthers","year":"1998","journal-title":"Dermatol Surg"},{"key":"2024011618052792900_sjad222-B3"},{"key":"2024011618052792900_sjad222-B4"},{"issue":"2","key":"2024011618052792900_sjad222-B5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/asj\/sjw272","article-title":"Liquid formulation of abobotulinumtoxinA exhibits a favorable efficacy and safety profile in moderate to severe glabellar lines: a randomized, double-blind, placebo- and active comparator-controlled trial","volume":"38","author":"Ascher","year":"2018","journal-title":"Aesthet Surg J"},{"issue":"1","key":"2024011618052792900_sjad222-B6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/asj\/sjz003","article-title":"Liquid formulation of abobotulinumtoxinA: a 6-month, Phase 3, double-blind, randomized, placebo-controlled study of a single treatment, ready-to-use toxin for moderate-to-severe glabellar lines","volume":"40","author":"Ascher","year":"2020","journal-title":"Aesthet Surg J"},{"issue":"3","key":"2024011618052792900_sjad222-B7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1093\/asj\/sjab329","article-title":"Long-term efficacy and safety of liquid abobotulinumtoxinA formulation for moderate-to-severe glabellar lines: a Phase III, double-blind, randomized, placebo-controlled and open-label study","volume":"42","author":"Kestemont","year":"2022","journal-title":"Aesthet Surg J"},{"issue":"9","key":"2024011618052792900_sjad222-B8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/asj\/sjz248","article-title":"Significantly increased patient satisfaction following liquid formulation abobotulinumtoxinA treatment in glabellar lines: FACE-Q outcomes from a Phase 3 clinical trial","volume":"40","author":"Ascher","year":"2020","journal-title":"Aesthet Surg J"},{"key":"2024011618052792900_sjad222-B9","author":"Gerber"},{"issue":"11","key":"2024011618052792900_sjad222-B10","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood unit)\u2014part I: upper facial wrinkles","volume":"24","author":"Ascher","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"2024011618052792900_sjad222-B11","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/j.1468-3083.2010.03728.x","article-title":"International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood unit)\u2014part II: wrinkles on the middle and lower face, neck and chest","volume":"24","author":"Ascher","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"2024011618052792900_sjad222-B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0094-1298(20)31899-X","article-title":"Patient selection and patient satisfaction","volume":"10","author":"Lewis","year":"1983","journal-title":"Clin Plast Surg"},{"issue":"11","key":"2024011618052792900_sjad222-B13","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1111\/jocd.13349","article-title":"Two multinational, observational surveys investigating perceptions of beauty and attitudes and experiences relating to aesthetic medical procedures","volume":"19","author":"Redaelli","year":"2020","journal-title":"J Cosmet Dermatol"},{"key":"2024011618052792900_sjad222-B14"},{"issue":"1","key":"2024011618052792900_sjad222-B15","doi-asserted-by":"publisher","first-page":"NP14","DOI":"10.1093\/asj\/sjv107","article-title":"Shared decision-making in cosmetic medicine and aesthetic surgery","volume":"36","author":"Ubbink","year":"2016","journal-title":"Aesthet Surg J"},{"issue":"8","key":"2024011618052792900_sjad222-B16","doi-asserted-by":"publisher","first-page":"NP254","DOI":"10.1093\/asj\/sjw067","article-title":"Shared decision-making and liability in aesthetic surgery","volume":"36","author":"Birkeland","year":"2016","journal-title":"Aesthet Surg J"},{"key":"2024011618052792900_sjad222-B17"},{"issue":"3-4","key":"2024011618052792900_sjad222-B18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1080\/14764170310023254","article-title":"How to avoid brow ptosis after forehead treatment with botulinum toxin","volume":"5","author":"Redaelli","year":"2003","journal-title":"J Cosmet Laser Ther"},{"issue":"12","key":"2024011618052792900_sjad222-B19","first-page":"E1","article-title":"Management of ptosis","volume":"9","author":"King","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"key":"2024011618052792900_sjad222-B20","volume-title":"Botulinum Toxin A in Aesthetic Medicine. Facial and Body Indications","author":"Redaelli","year":"2019","edition":"3rd ed"},{"key":"2024011618052792900_sjad222-B21","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1093\/asj\/sjac267","article-title":"Integrative assessment for optimizing aesthetic outcomes when treating glabellar lines with botulinum toxin type A: an appreciation of the role of the frontalis","author":"Bertucci","year":"2023"},{"issue":"2","key":"2024011618052792900_sjad222-B22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jocd.12090","article-title":"Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics","volume":"13","author":"Iozzo","year":"2014","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"2024011618052792900_sjad222-B23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/psn.0000000000000265","article-title":"Consideration of muscle depth for botulinum toxin injections: a three-dimensional approach","volume":"39","author":"Kaplan","year":"2019","journal-title":"Plast Surg Nurs"},{"issue":"3","key":"2024011618052792900_sjad222-B24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.prs.0000153236.79775.a0","article-title":"The use of botulinum toxin type A in aesthetic mandibular contouring","volume":"115","author":"Kim","year":"2005","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"2024011618052792900_sjad222-B25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/dss.0000000000002165","article-title":"Repeated full-face aesthetic combination treatment with abobotulinumtoxinA, hyaluronic acid filler, and skin-boosting hyaluronic acid after monotherapy with abobotulinumtoxinA or hyaluronic acid filler","volume":"46","author":"Cartier","year":"2020","journal-title":"Dermatol Surg"},{"issue":"1","key":"2024011618052792900_sjad222-B26","first-page":"83","article-title":"Injectable non-animal stabilized hyaluronic acid as a skin quality booster: an expert panel consensus","volume":"17","author":"Belmontesi","year":"2018","journal-title":"J Drugs Dermatol"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjad222\/51040157\/sjad222.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/44\/2\/192\/56143534\/sjad222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/44\/2\/192\/56143534\/sjad222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:12:28Z","timestamp":1705428748000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/44\/2\/192\/7231033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,7,25]]},"published-print":{"date-parts":[[2024,1,16]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjad222","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,7,25]]}}}